Clinical Research Informer

Grand Rounds October 27, 2023: Digital, Decentralized and Democratized: Lessons From The Yale PaxLC Trial (Harlan M. Krumholz, MD, SM)

Rethinking Clinical Trials

OCTOBER 31, 2023

Pfizer provided feedback. Tags #pctGR, @Collaboratory1 The post Grand Rounds October 27, 2023: Digital, Decentralized and Democratized: Lessons From The Yale PaxLC Trial (Harlan M. -Can you comment on the decision to make the PROMIS scale the primary outcome? Does it capture most what matters to patients?

Trials

Trials Medicine Research Clinical Trials

Grand Rounds October 28, 2022: The HERO (Healthcare Worker Exposure Response & Outcomes) Program: An Online Community to Support Observational Studies, Randomized Trials, and Long-Term Safety Surveillance (Emily O’Brien, PhD, FAHA; Russell Rothman, MD, MPP)

Rethinking Clinical Trials

NOVEMBER 1, 2022

Participant feedback revealed that shorter more targeted surveys focusing on the most high-value information may have been less burdensome for participants. pctGR, @Collaboratory1.

Trials

Trials Clinical Research Vaccination Vaccine

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH)

Rethinking Clinical Trials

AUGUST 28, 2023

GCTC will publish its comments at goodtrials.org and the public is encouraged to submit feedback as the work continues to improve the guidance. We encourage people to review the guidance and provide feedback. This could stifle innovation and quality when new and different technologies are more relevant.

Clinical Trials

Clinical Trials Clinical Trials Trials Development

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH; Adrian F. Hernandez, MD, MHS)

Rethinking Clinical Trials

AUGUST 28, 2023

GCTC will publish its comments at goodtrials.org and the public is encouraged to submit feedback as the work continues to improve the guidance. We encourage people to review the guidance and provide feedback. This could stifle innovation and quality when new and different technologies are more relevant.

Clinical Trials

Clinical Trials Clinical Trials Trials Development

Grand Rounds August 25, 2023: Pragmatic Trial of an EHR Application to Display Real-time PRO Data: Successes and Challenges (Gabriela Schmajuk, MD, MS)

Rethinking Clinical Trials

AUGUST 30, 2023

The team collected focus group feedback from patients and clinicians and worked with IT professionals to pull data directly from the electronic health record and design an interface that could be used by all patients. . However, there is a gap between collecting the PROs and communicating about the PROs with patients.

Trials

Trials Clinical Research Coordinator Medicine Clinical Trials

Grand Rounds November 17, 2023: Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications: Results from the Nudge Study (Michael Ho, MD, PhD; Sheana Bull, PhD)

Rethinking Clinical Trials

NOVEMBER 21, 2023

Nudge also deployed a text message and survey to participants to get a sense for patient satisfaction with feedback on the study and text messages. About 50% of participants responded with a question, and 9.2% responded with a question for a clinical pharmacist. – How did the messages account for prescription dosage changes?

Clinical Trials

Clinical Trials Clinical Trials Trials Development

Grand Rounds January 27, 2023: The PREPARE II Trial: Embedding a Pragmatic Trial Into Clinical Care During an Emergency Procedure (Derek W. Russell, MD; Matthew W. Semler, MD, MSc)

Rethinking Clinical Trials

FEBRUARY 2, 2023

There was a 1-page data collection sheet that trained site-specific observers completed with rapid feedback from research team on data quality. Tags #pctGR, @Collaboratory1 The post Grand Rounds January 27, 2023: The PREPARE II Trial: Embedding a Pragmatic Trial Into Clinical Care During an Emergency Procedure (Derek W.

Trials

Trials Clinical Trials Clinical Trials Medicine

Grand Rounds July 14, 2023: Lessons From the COORDINATE-Diabetes Trial (Christopher B. Granger, MD; Neha J. Pagidipati, MD, MPH)

Rethinking Clinical Trials

JULY 19, 2023

The intervention included assessment of local practices and barriers, development of strategies to overcome those barriers, and audit and feedback of quality metrics, with the goal of improving the way clinics approach treatment of these diseases. The second group of clinics implemented a multifaceted intervention at the provider level.

Trials

Trials Cardiology Medicine Nurses

Clover biopharmaceuticals raises $230 M; BrainStorm after ALS; BARDA grants $5.65 M LightDeck for SARS-CoV-2 antigen test; Libtayo for first-line advanced NSCLC subset

Delveinsight

FEBRUARY 23, 2021

The company plans to use the capital to expand its pipeline of protein-based vaccines and biologic cancer therapies utilizing its innovative and proprietary Trimer-Tag technology platform. BrainStorm Receives Feedback on BLA Submission for ALS.

In-Vitro

In-Vitro Vaccination Vaccine Licensing

Preview of Pharma Commercials at Super Bowl 2024: From Touching Down with TUMS to Tackling Menopause

XTalks

FEBRUARY 8, 2024

Along with the hefty price tag for screen time that may not be perceived to be a worthwhile investment, and despite favoring advertising at other major events like the Grammys, pharma tends to stay somewhat clear of all the Super Bowl hoopla.

Life Science

Life Science Marketing Branding Drugs

3 ways pharma marketers can draw inspiration from digitally-native brands

pharmaphorum

SEPTEMBER 15, 2020

“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. Jeremy Richter, Tag. Joe began his life at Tag in the UK, bringing efficiencies to his clients, working across all conceivable channels.

Branding

Branding Marketing Pharma Companies Life Science

Top email calamities to avoid … and how to make an impact instead

pharmaphorum

SEPTEMBER 29, 2021

If you have to say “no”, share sensitive feedback, settle an issue or for other discussions that require sufficient time, tact and the exchange of comprehensive information, do it in person, pick up the phone or schedule a video conference. What’s not for email. Email is not, however, a tool to lead complex discussions.

Life Science

Life Science Containment Sales Marketing

PentagonFit Fitness Tracker

The Pharma Data

MAY 15, 2021

Some of the customers featured in this advertisement were given free access to the PentagonFit tracker and/or program in exchange for their feedback. Web Beacons are tags that can monitor the behavior of a user visiting the Website or sending an e-mail. Customer service lines are open from 9 AM to 5 PM EST, Monday through Friday.

Production

Production Containment Medicine Vaccination

Clinical Research Informer

Grand Rounds October 27, 2023: Digital, Decentralized and Democratized: Lessons From The Yale PaxLC Trial (Harlan M. Krumholz, MD, SM)

Grand Rounds October 28, 2022: The HERO (Healthcare Worker Exposure Response & Outcomes) Program: An Online Community to Support Observational Studies, Randomized Trials, and Long-Term Safety Surveillance (Emily O’Brien, PhD, FAHA; Russell Rothman, MD, MPP)

Trending Sources

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH)

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH; Adrian F. Hernandez, MD, MHS)

Grand Rounds August 25, 2023: Pragmatic Trial of an EHR Application to Display Real-time PRO Data: Successes and Challenges (Gabriela Schmajuk, MD, MS)

Grand Rounds November 17, 2023: Personalized Patient Data and Behavioral Nudges to Improve Adherence to Chronic Cardiovascular Medications: Results from the Nudge Study (Michael Ho, MD, PhD; Sheana Bull, PhD)

Grand Rounds January 27, 2023: The PREPARE II Trial: Embedding a Pragmatic Trial Into Clinical Care During an Emergency Procedure (Derek W. Russell, MD; Matthew W. Semler, MD, MSc)

Grand Rounds July 14, 2023: Lessons From the COORDINATE-Diabetes Trial (Christopher B. Granger, MD; Neha J. Pagidipati, MD, MPH)

Clover biopharmaceuticals raises $230 M; BrainStorm after ALS; BARDA grants $5.65 M LightDeck for SARS-CoV-2 antigen test; Libtayo for first-line advanced NSCLC subset

Preview of Pharma Commercials at Super Bowl 2024: From Touching Down with TUMS to Tackling Menopause

3 ways pharma marketers can draw inspiration from digitally-native brands

Top email calamities to avoid … and how to make an impact instead

PentagonFit Fitness Tracker

Stay Connected